ATS Corporation (TSX and NYSE: ATS) (“ATS” or the “Company”)
today reported its financial results for the three and twelve
months ended March 31, 2024. All references to "$" or "dollars" in
this news release are to Canadian dollars unless otherwise
indicated.
Fourth quarter highlights:
- Revenues increased 8.3% year over year to $791.5 million.
- Net Income was $48.5 million compared to $29.6 million a year
ago.
- Basic earnings per share were 49 cents, compared to 32 cents a
year ago.
- Adjusted EBITDA1 was $115.8 million, 2.0% lower compared to
$118.2 million a year ago.
- Adjusted basic earnings per share1 were 65 cents compared to 73
cents a year ago.
- Order Bookings1 were $791 million, 7.3% higher compared to $737
million a year ago.
- Order Backlog1 was $1,793 million at the end of the
quarter.
"Today ATS reported record fourth quarter revenues and strong
Order Bookings," said Andrew Hider, Chief Executive Officer. "Our
Order Backlog positions us well for fiscal '25 , and we look
forward to the addition of Paxiom Group to ATS' portfolio, as we
maintain our focus on long-term value creation."
Year-to-date highlights:
- Revenues increased 17.7% year over year to $3,032.9
million.
- Net Income increased 52.1% year over year to $194.2
million.
- Basic earnings per share increased 42.4% year over year to
$1.98.
- Adjusted EBITDA1 increased 17.3% year over year to $470.6
million.
- Adjusted basic earnings per share1 increased 10.1% year over
year to $2.61.
- Order Bookings1 were $2,891 million, compared to $3,256 million
a year ago.
Mr. Hider added: “In fiscal 2024 we delivered profitable growth
on revenues of over $3 billion, the highest in company history,
along with record adjusted earnings. Our global team of over 7,000
employees continues to execute across our strategic markets, and
drive improvement in the business through ongoing application of
our ATS Business Model."
1 Non-IFRS measure: see “Notice to Reader:
Non-IFRS and Other Financial Measures”.
Financial results
(In millions of dollars, except per share
and margin data)
Q4 2024
Q4 2023
Variance
Fiscal 2024
Fiscal 2023
Variance
Revenues
$
791.5
$
730.8
8.3
%
$
3,032.9
$
2,577.4
17.7
%
Net income
$
48.5
$
29.6
63.9
%
$
194.2
$
127.7
52.1
%
Adjusted earnings from
operations1
$
95.9
$
101.9
(5.9
)%
$
397.5
$
343.4
15.8
%
Adjusted earnings from operations
margin1
12.1
%
13.9
%
(183)bps
13.1
%
13.3
%
(22)bps
Adjusted EBITDA1
$
115.8
$
118.2
(2.0
)%
$
470.6
$
401.2
17.3
%
Adjusted EBITDA margin1
14.6
%
16.2
%
(154)bps
15.5
%
15.6
%
(5)bps
Basic earnings per share
$
0.49
$
0.32
53.1
%
$
1.98
$
1.39
42.4
%
Adjusted basic earnings per
share
$
0.65
$
0.73
(11.0
)%
$
2.61
$
2.37
10.1
%
Order Bookings1
$
791.0
$
737.0
7.3
%
$
2,891.0
$
3,256.0
(11.2
)%
As At
March 31 2024
March 31 2023
Variance
Order Backlog1
$
1,793
$
2,153
(16.7
)%
1 Non-IFRS financial measure - See
“Non-IFRS and Other Financial Measures."
Recent Acquisitions
On May 15, 2024, the Company announced it had entered into a
definitive agreement to acquire Paxiom Group (“Paxiom”). With
headquarters in Montreal, Quebec, Paxiom is a provider of primary,
secondary, and end-of-line packaging machines in the food and
beverage, cannabis, and pharmaceutical industries. Paxiom provides
a vast product line that includes precision weight filling,
bagging, wrapping, labeling, conveyors, case forming, robotic case
packing and end of line palletizing equipment that will complement
ATS’ businesses CFT S.p.A, Raytec Vision S.p.A, Marco Limited, IWK
Verpackungstechnik GmbH, and NCC Automated Systems, Inc. and allow
ATS to offer complete packaging and end-of-line solutions. The
transaction is expected to close in the third calendar quarter of
2024, subject to customary closing conditions.
On January 1, 2024, the Company acquired IT.ACA. Engineering
S.r.l ("IT.ACA"), an Italian automation system integrator. IT.ACA
strengthens process automation solutions business ("PA") market
position in southern Europe, while also adding strong capabilities
aligned with PA's in automation integration, digitalization, and
production process optimization.
Fourth quarter summary
Fiscal 2024 fourth quarter revenues were 8.3% or $60.7 million
higher than in the corresponding period a year ago. This
performance primarily reflected year-over-year organic revenue
growth (growth excluding contributions from acquired companies and
foreign exchange translation) of $25.3 million or 3.5%, and
revenues earned by acquired companies of $34.0 million, which
included $24.8 million from Avidity. Revenues generated from
construction contracts increased 6.0% or $28.3 million due to
organic revenue growth. Revenues from services increased 23.9% or
$32.9 million due to organic revenue growth in addition to revenues
earned by acquired companies of $12.9 million. Revenues from the
sale of goods decreased 0.4% or $0.5 million primarily due to lower
Order Backlog entering the quarter, partially offset by revenues
earned by acquired companies of $20.6 million, primarily from
Avidity.
By market, revenues generated in life sciences increased $50.7
million or 15.6% year over year. This was primarily due to
contributions from acquisitions totalling $28.3 million and organic
revenue growth on higher Order Backlog entering the quarter.
Revenues in transportation increased $23.1 million or 11.6%, due to
timing of program execution. Revenues generated in food &
beverage increased $0.6 million or 0.6% due to revenues earned by
acquired companies. Revenues generated in consumer products
decreased $12.1 million or 14.7% due to timing of program
execution. Revenues in energy decreased $1.6 million or 6.2% due to
timing of program execution.
Net income for the fourth quarter of fiscal 2024 was $48.5
million (49 cents per share basic), compared to $29.6 million (32
cents per share basic) for the fourth quarter of fiscal 2023. The
increase primarily reflected higher revenues, lower stock-based
compensation expenses and lower restructuring charges, partially
offset by higher cost of revenues and selling, general and
administrative ("SG&A") expenses. Adjusted basic earnings per
share were 65 cents compared to 73 cents in the fourth quarter of
fiscal 2023 (see “Reconciliation of Non-IFRS Measures to IFRS
Measures”).
Depreciation and amortization expense was $36.3 million in the
fourth quarter of fiscal 2024, compared to $33.9 million a year
ago; the increase was primarily related to incremental depreciation
and amortization expense from recently acquired companies.
EBITDA was $111.1 million (14.0% EBITDA margin) in the fourth
quarter of fiscal 2024 compared to $85.8 million (11.7% EBITDA
margin) in the fourth quarter of fiscal 2023. EBITDA for the fourth
quarter of fiscal 2024 included $6.6 million of restructuring
charges, $4.6 million of incremental costs related to acquisition
activity, $2.0 million of acquisition-related fair value
adjustments to acquired inventories, and a $8.5 million recovery of
stock-based compensation expenses due to revaluation. EBITDA for
the corresponding period in the prior year included $1.5 million of
incremental costs related to acquisition activity, $15.8 million of
restructuring charges, and $15.1 million of stock-based
compensation revaluation expenses. Excluding these costs, adjusted
EBITDA was $115.8 million (14.6% adjusted EBITDA margin), compared
to $118.2 million (16.2% adjusted EBITDA margin) for the
corresponding period in the prior year. Lower adjusted EBITDA
reflected increased SG&A expenses and cost of revenues,
partially offset by higher revenues. EBITDA is a non-IFRS financial
measure - see “Non-IFRS and Other Financial Measures.”
Order Backlog
Continuity
(In millions of dollars)
Q4 2024
Q4 2023
Fiscal 2024
Fiscal 2023
Opening Order Backlog
$
1,907
$
2,143
$
2,153
$
1,438
Revenues
(792
)
(731
)
(3,033
)
(2,577
)
Order Bookings
791
737
2,891
3,256
Order Backlog adjustments1
(113
)
4
(218
)
36
Total
$
1,793
$
2,153
$
1,793
$
2,153
1. Order Backlog adjustments include
incremental Order Backlog of acquired companies ($4 million
acquired with Avidity Science, LLC ("Avidity" in the twelve months
ended March 31, 2024, and in fiscal 2023, $9 million acquired with
Zi-Argus Australia Pty Ltd. and Zi-Argus Ltd. and $5 million
acquired with Triad Unlimited LLC in the three and twelve months
ended March 31, 2023, $14 million acquired with IPCOS Group N.V. in
the twelve months ended March 31, 2023), as well as foreign
exchange adjustments, scope changes and cancellations.
Order Bookings
Fourth quarter fiscal 2024 Order Bookings were $791 million, a
7.3% year over year increase, reflecting 5.2% growth from acquired
companies, in addition to organic Order Bookings of 2.1%. Order
Bookings from acquired companies totalled $38.7 million. By market,
Order Bookings in life sciences increased compared to the
prior-year period primarily due to organic growth, along with $28.7
million of contributions from acquired companies, including $22.7
million from Avidity. Order Bookings in transportation decreased
compared to the prior-year period, which included Order Bookings of
U.S. $119.9 million (approximately $162.2 million CAD) from a
global automotive customer to move towards fully automated battery
assembly systems for their North American manufacturing operations.
Order Bookings in food & beverage increased primarily due to
timing of customer projects. Order Bookings in consumer products
decreased slightly as a result of the timing of customer projects,
offset by contributions from acquired companies. Order Bookings in
energy increased primarily due to timing of customer projects.
Trailing twelve month book-to-bill ratio at March 31, 2024 was
0.95:1. Book-to-bill ratio is a supplementary financial measure -
see “Non-IFRS and Other Financial Measures.”
Backlog
At March 31, 2024, Order Backlog was $1,793 million, 16.7% lower
than at March 31, 2023 primarily on account of lower Order Backlog
within the transportation market which included several large Order
Bookings a year ago.
Outlook
The life sciences funnel remains strong, with a focus on
strategic submarkets of pharmaceuticals, radiopharmaceuticals, and
medical devices. Management continues to see opportunities with
both new and existing customers, including those who produce
auto-injectors and wearable devices for diabetes and obesity
treatments, contact lenses and pre-filled syringes, as well as
opportunities to provide life science solutions that leverage
integrated capabilities from across ATS. Management expects
revenues from programs related to GLP-1 drugs and associated drug
delivery solutions, such as auto- injectors, to move towards a high
single digit percentage of total revenues over the next several
years. In transportation, the funnel is comprised of smaller
shorter-term opportunities, relative to the larger Order Bookings
received throughout fiscal years 2023 and 2024, and some of those
larger opportunities have also moved further into the future,
reflecting Original Equipment Manufacturers taking a more measured
approach, aligning capacity and platform costs with market demand.
Management believes the Company's automated electric vehicle ("EV")
battery pack and assembly capabilities position ATS well within the
industry as the market continues to evolve. Funnel activity in food
& beverage remains strong, particularly for energy-efficient
solutions. The Company continues to benefit from strong brand
recognition within the global tomato processing industry, and there
is continued interest in automated solutions within the food &
beverage market more broadly. Funnel activity in consumer products
is stable; inflationary pressures continue to have an effect on
discretionary spending by consumers, which may impact timing of
some customer investments. Funnel activity in energy remains strong
and includes longer-term opportunities in the nuclear industry. The
Company is focused on clean energy applications including solutions
for the refurbishment of nuclear power plants, early participation
in the small modular reactor market, and grid battery storage.
Across all markets, customers are exercising normal caution in
their approach to investment and spending. Funnel growth in markets
where environmental, social and governance requirements are an
increasing focus for customers — including grid battery storage, EV
and nuclear, as well as consumer goods packaging — provide ATS with
opportunities to use its capabilities to respond to customer
sustainability standards and goals, including global and regional
requirements to reduce carbon emissions. Customers seeking to
de-risk or enhance the resiliency of their supply chains, address a
shortage of skilled workers or combat higher labour costs also
provide future opportunities for ATS to pursue. Management believes
that the underlying trends driving customer demand for ATS
solutions including rising labour costs, labour shortages,
production onshoring or reshoring and the need for scalable,
high-quality, energy-efficient production remain favourable.
Order Backlog of $1,793 million is expected to help mitigate
some of the impact of quarterly variability in Order Bookings on
revenues in the short term. The Company’s Order Backlog includes
several large enterprise programs that have longer periods of
performance and therefore longer revenue recognition cycles. In the
first quarter of fiscal 2025, management expects the conversion of
Order Backlog to revenues to be in the 36% to 40% range. This
estimate is calculated each quarter based on management’s
assessment of project schedules across all customer contracts,
expectations for faster- turn product and services revenues,
expected delivery timing of third-party equipment and operational
capacity. In the third quarter, management disclosed that
approximately $200 million of Order Backlog with one of the
Company's EV customers was delayed. During the fourth quarter,
approximately $50 million of Order Backlog on this portion of the
program was reduced to reflect scope changes, partially offset by
increased scope changes in other areas of the overall program with
this same customer. Management continues to work with this customer
to support their revised timing as they realign their production
schedules on this portion of the program. This delay is accounted
for in the first-quarter revenue conversion range. Management
expects some pressure on EV revenues in the short-term as ATS
continues to execute on existing EV Order Backlog. For fiscal 2025,
despite expected lower revenues from EV, Management believes that
ATS is well-positioned to drive revenue growth in other markets,
including life sciences and expects this growth, combined with the
addition of Paxiom will largely offset reduced volumes from EV.
The timing of customer decisions on larger opportunities is
expected to cause variability in Order Bookings from quarter to
quarter. Revenues in a given period are dependent on a combination
of the volume of outstanding projects the Company is contracted to
perform, the size and duration of those projects, and the timing of
project activities including design, assembly, testing, and
installation. Given the specialized nature of the Company’s
offerings, the size and scope of projects vary based on customer
needs. The Company seeks to achieve revenue growth organically and
by identifying strategic acquisition opportunities that provide
access to attractive end-markets and new products and technologies
and deliver hurdle-rate returns. After-sales revenues and
reoccurring revenues, which ATS defines as revenues from ancillary
products and services associated with equipment sales, and revenues
from customers who purchase non-customized ATS product at regular
intervals, are expected to provide some balance to customers'
capital expenditure cycles. Management estimates that reoccurring
revenues are currently in the range of 25% to 35% of total revenues
on a trailing twelve- month basis.
In the short term, ATS expects it will continue to mitigate
supply chain volatility. Lead times have improved in most key
categories; however, prolonged cost increases, price and lead-time
volatility have and may continue to disrupt the timing and progress
of the Company’s margin expansion efforts and affect revenue
recognition. In addition, short-term revenue pressure related to EV
programs could impact margins. However, Management expects to be
able to manage the Company's cost structure over time through
flexible resourcing, including but not limited to subcontract
labour and redeploying resources to other parts of the business.
Over time, sustaining management's margin target assumes that the
Company will successfully implement its margin expansion
initiatives, and that such initiatives will result in improvements
to its adjusted earnings from operations margin that offset these
shorter- term pressures (see “Forward-Looking Statements” for a
description of the risks underlying the achievement of the margin
target in future periods).
In the short term, the Company expects non-cash working capital
to remain elevated as large enterprise programs progress through
milestones. Over the long-term, the Company expects to continue
investing in non-cash working capital to support growth, with
fluctuations expected on a quarter-over-quarter basis. The
Company’s long-term goal is to maintain its investment in non-cash
working capital as a percentage of annualized revenues below 15%.
However, given the size and timing of milestone payments for
certain large EV programs in Order Backlog, the Company could see
its working capital exceed 15% of annualized revenues in certain
periods as it did throughout fiscal 2024. The Company expects that
continued cash flows from operations, together with cash and cash
equivalents on hand and credit available under operating and
long-term credit facilities will be sufficient to fund its
requirements for investments in non-cash working capital and
capital assets, and to fund strategic investment plans including
some potential acquisitions. Acquisitions could result in
additional debt or equity financing requirements for the Company.
Non-cash working capital as a percentage of revenues is a non-IFRS
ratio - see “Non-IFRS and Other Financial Measures.”
The Company continues to make progress in line with its plans to
integrate acquired companies, and expects to realize cost and
revenue synergies consistent with announced integration plans.
Reorganization Activity
The Company periodically undertakes reviews of its operations to
ensure alignment with strategic market opportunities. As a part of
this review, the Company has identified and previously announced an
opportunity to improve the cost structure of the organization and
reallocate investment to growth areas. Resulting actions started in
the third quarter of fiscal 2024 and continued through fiscal year
end. Restructuring expenses of $6.6 million were recorded in the
fourth quarter, and for the full year, total costs of $22.8 million
were recorded, including actions to address expected lower EV
volumes in fiscal 2025.
Quarterly Conference Call
ATS will host a conference call and webcast at 8:30 a.m. eastern
on Thursday, May 16, 2024 to discuss its quarterly results. The
listen-only webcast can be accessed live at www.atsautomation.com.
The conference call can be accessed live by dialing (888) 660-6652
or (646) 960-0554 five minutes prior. A replay of the conference
will be available on the ATS website following the call.
Alternatively, a telephone recording of the call will be available
for one week (until midnight May 23, 2024) by dialing (800)
770-2030 and using the access code 8782510.
About ATS
ATS Corporation is an industry-leading automation solutions
provider to many of the world's most successful companies. ATS uses
its extensive knowledge base and global capabilities in custom
automation, repeat automation, automation products and value-added
solutions including pre-automation and after-sales services, to
address the sophisticated manufacturing automation systems and
service needs of multinational customers in markets such as life
sciences, transportation, food & beverage, consumer products,
and energy. Founded in 1978, ATS employs over 7,000 people at more
than 65 manufacturing facilities and over 85 offices in North
America, Europe, Southeast Asia and Oceania. The Company's common
shares are traded on the Toronto Stock Exchange ("TSX") and the New
York Stock Exchange ("NYSE") under the symbol ATS. Visit the
Company's website at www.atsautomation.com.
SOURCE: ATS Corporation
Consolidated Revenues
(In millions of dollars)
Revenues by type
Q4 2024
Q4 2023
Fiscal 2024
Fiscal 2023
Revenues from construction
contracts
$
499.0
$
470.7
$
1,972.8
$
1,630.4
Services rendered
170.3
137.4
614.7
492.3
Sale of goods
122.2
122.7
445.4
454.7
Total revenues
$
791.5
$
730.8
$
3,032.9
$
2,577.4
Revenues by market
Q4 2024
Q4 2023
Fiscal 2024
Fiscal 2023
Life Sciences
$
375.2
$
324.5
$
1,268.6
$
1,209.9
Transportation
222.2
199.1
933.3
578.2
Food & Beverage
99.7
99.1
435.0
371.3
Consumer Products
70.1
82.2
287.2
305.1
Energy
24.3
25.9
108.8
112.9
Total revenues
$
791.5
$
730.8
$
3,032.9
$
2,577.4
Revenues by customer
location
Q4 2024
Q4 2023
Fiscal 2024
Fiscal 2023
North America
$
468.0
$
438.1
$
1,766.5
$
1,525.5
Europe
247.1
237.8
990.1
811.7
Asia/Other
76.4
54.9
276.3
240.2
Total revenues
$
791.5
$
730.8
$
3,032.9
$
2,577.4
Additional revenue
disaggregation
Q4 2024
Q4 2023
Fiscal 2024
Fiscal 2023
Custom integration
$
367.7
$
329.0
$
1,422.3
$
1,143.3
Products and equipment
$
197.7
$
209.8
$
783.6
$
747.2
Services including spare
parts
$
226.1
$
192.0
$
827.0
$
686.9
Total revenues
$
791.5
$
730.8
$
3,032.9
$
2,577.4
Consolidated Operating
Results
(In millions of dollars)
Q4 2024
Q4 2023
Fiscal 2024
Fiscal 2023
Earnings from
operations
$
74.8
$
51.9
$
315.4
$
222.5
Amortization of
acquisition-related intangible assets
16.4
17.6
68.1
67.7
Acquisition-related transaction
costs
4.6
1.5
6.8
3.1
Acquisition-related inventory
fair value charges
2.0
—
2.8
9.2
Gain on sale of facilities
—
—
(11.7
)
—
Restructuring charges
6.6
15.8
22.8
27.5
Mark to market portion of
stock-based compensation
(8.5
)
15.1
(6.7
)
13.4
Adjusted earnings from
operations1
$
95.9
$
101.9
$
397.5
$
343.4
1 Non-IFRS Financial Measure, See
“Non-IFRS and Other Financial Measures”
Q4 2024
Q4 2023
Fiscal 2024
Fiscal 2023
Earnings from
operations
$
74.8
$
51.9
$
315.4
$
222.5
Depreciation and amortization
36.3
33.9
141.2
125.5
EBITDA1
$
111.1
$
85.8
$
456.6
$
348.0
Restructuring charges
6.6
15.8
22.8
27.5
Acquisition-related transaction
costs
4.6
1.5
6.8
3.1
Acquisition-related inventory
fair value charges
2.0
—
2.8
9.2
Mark to market portion of
stock-based compensation
(8.5
)
15.1
(6.7
)
13.4
Gain on sale of facilities
—
—
(11.7
)
—
Adjusted EBITDA1
$
115.8
$
118.2
$
470.6
$
401.2
1 Non-IFRS Financial Measure, See
“Non-IFRS and Other Financial Measures”
Order Backlog by
Market
(In millions of dollars)
As at
March 31, 2024
March 31, 2023
Life Sciences
$
871
$
761
Transportation
425
939
Food & Beverage
230
215
Consumer Products
156
156
Energy
111
82
Total
$
1,793
$
2,153
Order Bookings by
Quarter
(In millions of dollars)
Fiscal 2024
Fiscal 2023
Q1
$
690
$
736
Q2
742
804
Q3
668
979
Q4
791
737
Total Order Bookings
$
2,891
$
3,256
Reconciliation of Non-IFRS Measures to
IFRS Measures
(In millions of dollars, except per share
data)
The following table reconciles adjusted
EBITDA and EBITDA to the most directly comparable IFRS measure (net
income):
Q4 2024
Q4 2023
Fiscal 2024
Fiscal 2023
Adjusted EBITDA
$
115.8
$
118.2
$
470.6
$
401.2
Less: restructuring charges
6.6
15.8
22.8
27.5
Less: acquisition-related
transaction costs
4.6
1.5
6.8
3.1
Less: acquisition-related
inventory fair value charges
2.0
—
2.8
9.2
Less: mark to market portion of
stock-based compensation
(8.5
)
15.1
(6.7
)
13.4
Less: gain on sale of
facilities
—
—
(11.7
)
—
EBITDA
$
111.1
$
85.8
$
456.6
$
348.0
Less: depreciation and
amortization expense
36.3
33.9
141.2
125.5
Earnings from
operations
$
74.8
$
51.9
$
315.4
$
222.5
Less: net finance costs
18.8
18.8
68.7
62.7
Less: provision for income
taxes
7.5
3.5
52.5
32.1
Net income
$
48.5
$
29.6
$
194.2
$
127.7
The following table reconciles adjusted earnings from
operations, adjusted net income, and adjusted basic earnings per
share to the most directly comparable IFRS measure (net income and
basic earnings per share):
Three Months Ended March 31,
2024
Three Months Ended March 31,
2023
Earnings from
operations
Finance costs
Provision for income
taxes
Net income
Basic EPS
Earnings from operations
Finance costs
Provision for income taxes
Net income
Basic EPS
Reported (IFRS)
$
74.8
$
(18.8
)
$
(7.5
)
$
48.5
$
0.49
$
51.9
$
(18.8
)
$
(3.5
)
$
29.6
$
0.32
Amortization of acquisition-
related intangibles
16.4
—
—
16.4
0.16
17.6
—
—
17.6
0.19
Restructuring charges
6.6
—
—
6.6
0.07
15.8
—
—
15.8
0.17
Acquisition-related inventory
fair value charges
2.0
—
—
2.0
0.02
—
—
—
—
—
Acquisition-related transaction
costs
4.6
—
—
4.6
0.05
1.5
—
—
1.5
0.02
Mark to market portion of
stock-based compensation
(8.5
)
—
—
(8.5
)
(0.09
)
15.1
—
—
15.1
0.17
Tax effect adjustments1
—
—
(5.3
)
(5.3
)
(0.05
)
—
—
(12.9
)
(12.9
)
(0.14
)
Adjusted (non-IFRS)
$
95.9
$
64.3
$
0.65
$
101.9
$
66.7
$
0.73
1 Adjustments to provision for income
taxes relate to the income tax effects of adjustment items that are
excluded for the purposes of calculating non-IFRS based adjusted
net income.
Year Ended March 31,
2024
Year Ended March 31, 2023
Earnings from
operations
Finance costs
Provision for income
taxes
Net income
Basic EPS
Earnings from operations
Finance costs
Provision for income taxes
Net income
Basic EPS
Reported (IFRS)
$
315.4
$ (68.7)
$(52.5
)
$
194.2
$
1.98
$
222.5
$
(62.7
)
$
(32.1
)
$
127.7
$
1.39
Amortization of acquisition-
related intangibles
68.1
—
—
68.1
0.70
67.7
—
—
67.7
0.74
Restructuring charges
22.8
—
—
22.8
0.23
27.5
—
—
27.5
0.30
Acquisition-related fair value
inventory charges
2.8
—
—
2.8
0.03
9.2
—
—
9.2
0.10
Acquisition-related transaction
costs
6.8
—
—
6.8
0.07
3.1
—
—
3.1
0.03
Mark to market portion of
stock-based compensation
(6.7
)
—
—
(6.7
)
(0.07
)
13.4
—
—
13.4
0.14
Gain on sale of facilities
(11.7
)
—
—
(11.7
)
(0.12
)
—
—
—
—
—
Tax effect of the above
adjustments1
—
(21.0
)
(21.0
)
(0.21
)
—
—
(30.7
)
(30.7
)
(0.33
)
Adjusted (non-IFRS)
$
397.5
$
255.3
$
2.61
$
343.4
$
217.9
$
2.37
1 Adjustments to provision for income
taxes relate to the income tax effects of adjustment items that are
excluded for the purposes of calculating non-IFRS based adjusted
net income.
The following table reconciles organic revenue to the most
directly comparable IFRS measure (revenue):
Q4 2024
Q4 2023
Fiscal 2024
Fiscal 2023
Organic revenue
$
756.1
$
702.7
$
2,852.6
$
2,382.1
Revenues of acquired
companies
34.0
4.8
93.5
201.7
Impact of foreign exchange rate
changes
1.4
23.3
86.8
(6.4
)
Total revenue
$
791.5
$
730.8
$
3,032.9
$
2,577.4
Organic revenue growth
3.5
%
10.7
%
The following table reconciles non-cash working capital as a
percentage of revenues to the most directly comparable IFRS
measures:
As at
March 31 2024
March 31 2023
Accounts receivable
$
471.3
$
399.7
Income tax receivable
13.4
15.2
Contract assets
704.7
527.0
Inventories
295.9
256.9
Deposits, prepaids and other
assets
98.2
93.4
Accounts payable and accrued
liabilities
(604.5
)
(647.6
)
Income tax payable
(44.7
)
(38.9
)
Contract liabilities
(312.2
)
(296.6
)
Provisions
(36.0
)
(30.6
)
Non-cash working
capital
$
586.1
$
278.5
Trailing six-month revenues
annualized
$
3,087.0
$
2,755.6
Working capital %
19.0
%
10.1
%
The following table reconciles net debt to adjusted EBITDA to
the most directly comparable IFRS measures:
As at
March 31
2024
March 31
2023
Cash and cash equivalents
$
170.2
$
159.9
Bank indebtedness
(4.1
)
(5.8
)
Current portion of lease
liabilities
(27.6
)
(24.0
)
Current portion of long-term
debt
(0.2
)
(0.1
)
Long-term lease liabilities
(83.8
)
(73.3
)
Long-term debt
(1,171.8
)
(1,155.7
)
Net Debt
$
(1,117.3
)
$
(1,099.0
)
Adjusted EBITDA (TTM)
$
470.6
$
401.2
Net Debt to Adjusted
EBITDA
2.4x
2.7x
The following table reconciles free cash flow to the most
directly comparable IFRS measures:
(in millions of dollars)
Q4 2024
Q4 2023
Fiscal 2024
Fiscal 2023
Cash flows provided by operating
activities
$
9.6
$
81.4
$
20.8
$
127.8
Acquisition of property, plant
and equipment
(12.3
)
(23.4
)
(58.8
)
(56.1
)
Acquisition of intangible
assets
(13.6
)
(10.1
)
(29.6
)
(24.2
)
Free cash flow
$
(16.3
)
$
47.9
$
(67.6
)
$
47.5
Certain non-IFRS financial measures exclude the impact on
stock-based compensation expense of the revaluation of deferred
stock units and restricted share units resulting specifically from
the change in market price of the Company's common shares between
periods. Management believes the adjustment provides further
insight into the Company's performance.
The following table reconciles total stock-based compensation
expense to its components:
(in millions of dollars)
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Total stock-based compensation expense
$
(4.3
)
$
4.7
$
3.5
$
10.0
$
19.3
$
9.9
$
5.3
$
(4.0
)
Less: Mark to market portion of
stock-based compensation
(8.5
)
(0.6
)
(2.0
)
4.4
15.1
5.6
1.0
(8.3
)
Base stock-based compensation
expense
$
4.2
$
5.3
$
5.5
$
5.6
$
4.2
$
4.3
$
4.3
$
4.3
INVESTMENTS, LIQUIDITY, CASH FLOW AND FINANCIAL RESOURCES
(In millions of dollars, except
ratios)
As at
March 31, 2024
March 31, 2023
Cash and cash equivalents
$
170.2
$
159.9
Debt-to-equity ratio1
0.79:1
1.18:1
1 Debt is calculated as bank indebtedness,
long-term debt and lease liabilities. Equity is calculated as total
equity less accumulated other comprehensive income.
Q4 2024
Q4 2023
Fiscal 2024
Fiscal 2023
Cash, beginning of period
$
260.9
$
302.1
$
159.9
$
135.3
Total cash provided by (used
in):
Operating activities
9.6
81.4
20.8
127.8
Investing activities
(26.3
)
(66.9
)
(341.8
)
(109.0
)
Financing activities
(75.4
)
(155.9
)
330.7
4.9
Net foreign exchange
difference
1.4
(0.8
)
0.6
0.9
Cash, end of period
$
170.2
$
159.9
$
170.2
$
159.9
ATS CORPORATION
Consolidated Statements of
Financial Position
(in thousands of Canadian
dollars)
As at March 31
2024
2023
ASSETS
Current assets
Cash and cash equivalents
$
170,177
$
159,867
Accounts receivable
471,345
399,741
Income tax receivable
13,428
15,160
Contract assets
704,703
526,990
Inventories
295,880
256,866
Deposits, prepaids and other
assets
98,161
93,350
1,753,694
1,451,974
Non-current assets
Property, plant and equipment
296,977
263,119
Right-of-use assets
105,661
94,212
Other assets
18,416
16,679
Goodwill
1,228,600
1,118,262
Intangible assets
679,547
593,210
Deferred income tax assets
5,904
6,337
2,335,105
2,091,819
Total assets
$
4,088,799
$
3,543,793
LIABILITIES AND EQUITY
Current liabilities
Bank indebtedness
$
4,060
$
5,824
Accounts payable and accrued
liabilities
604,488
647,629
Income tax payable
44,732
38,904
Contract liabilities
312,204
296,555
Provisions
35,978
30,600
Current portion of lease
liabilities
27,571
23,994
Current portion of long-term
debt
176
65
1,029,209
1,043,571
Non-current
liabilities
Employee benefits
24,585
25,486
Long-term lease liabilities
83,808
73,255
Long-term debt
1,171,796
1,155,721
Deferred income tax
liabilities
81,353
104,459
Other long-term liabilities
14,101
10,718
1,375,643
1,369,639
Total liabilities
$
2,404,852
$
2,413,210
EQUITY
Share capital
$
865,897
$
520,633
Contributed surplus
26,119
15,468
Accumulated other comprehensive
income
64,155
60,040
Retained earnings
724,495
530,707
Equity attributable to
shareholders
1,680,666
1,126,848
Non-controlling interests
3,281
3,735
Total equity
1,683,947
1,130,583
Total liabilities and
equity
$
4,088,799
$
3,543,793
Please refer to complete Consolidated Financial Statements for
supplemental notes which can be found on the Company’s profile on
SEDAR+ at www.sedarplus.com, the Company's profile on the U.S.
Securities and Exchange Commission's website at www.sec.gov, and on
the Company’s website at www.atsautomation.com.
ATS CORPORATION
Consolidated Statements of
Income
(in thousands of Canadian
dollars, except per share amounts)
Years ended March 31
2024
2023
Revenues
$
3,032,883
$
2,577,384
Operating costs and expenses
Cost of revenues
2,177,379
1,851,574
Selling, general and
administrative
503,533
445,242
Restructuring costs
22,790
27,487
Stock-based compensation
13,790
30,592
Earnings from
operations
315,391
222,489
Net finance costs
68,704
62,718
Income before income
taxes
246,687
159,771
Income tax expense
52,506
32,070
Net income
$
194,181
$
127,701
Attributable to
Shareholders
$
193,735
$
127,433
Non-controlling interests
446
268
$
194,181
$
127,701
Earnings per share
attributable to shareholders
Basic
$
1.98
$
1.39
Diluted
$
1.97
$
1.38
Please refer to complete Consolidated Financial Statements for
supplemental notes which can be found on the Company’s profile on
SEDAR+ at www.sedarplus.com, the Company's profile on the U.S.
Securities and Exchange Commission's website at www.sec.gov, and on
the Company’s website at www.atsautomation.com.
ATS CORPORATION
Consolidated Statements of
Cash Flows
(in thousands of Canadian
dollars)
Years ended March 31
2024
2023
Operating activities
Net income
$
194,181
$
127,701
Items not involving cash
Depreciation of property, plant
and equipment
28,455
25,590
Amortization of right-of-use
assets
29,656
24,060
Amortization of intangible
assets
83,063
75,839
Deferred income taxes
(29,915
)
(37,542
)
Other items not involving
cash
(20,277
)
16,470
Stock-based compensation
11,253
5,088
Change in non-cash operating
working capital
(275,636
)
(109,406
)
Cash flows provided by
operating activities
$
20,780
$
127,800
Investing activities
Acquisition of property, plant
and equipment
$
(58,830
)
$
(56,104
)
Acquisition of intangible
assets
(29,628
)
(24,192
)
Business acquisitions, net of
cash acquired
(276,538
)
(51,679
)
Settlement of cross-currency
interest rate swap instrument
—
21,493
Proceeds from disposal of
property, plant and equipment
23,211
1,460
Cash flows used in investing
activities
$
(341,785
)
$
(109,022
)
Financing activities
Bank indebtedness
$
(1,527
)
$
3,399
Repayment of long-term debt
(798,378
)
(344,169
)
Proceeds from long-term debt
816,514
395,559
Proceeds from exercise of stock
options
2,152
4,964
Proceeds from U.S. initial public
offering, net of issuance fees
362,072
—
Purchase of non-controlling
interest
(195
)
(452
)
Repurchase of common shares
(14
)
(21,071
)
Acquisition of shares held in
trust
(23,820
)
(12,365
)
Principal lease payments
(26,080
)
(20,983
)
Cash flows provided by
financing activities
$
330,724
$
4,882
Effect of exchange rate changes
on cash and cash equivalents
591
925
Increase in cash and cash
equivalents
10,310
24,585
Cash and cash equivalents,
beginning of year
159,867
135,282
Cash and cash equivalents, end
of year
$
170,177
$
159,867
Supplemental
information
Cash income taxes paid
$
49,511
$
58,398
Cash interest paid
$
68,526
$
58,452
Please refer to complete Consolidated Financial Statements for
supplemental notes which can be found on the Company’s profile on
SEDAR+ at www.sedarplus.com, the Company's profile on the U.S.
Securities and Exchange Commission's website at www.sec.gov, and on
the Company’s website at www.atsautomation.com.
Notice to Readers: Non-IFRS and Other Financial
Measures
Throughout this document, management uses certain non-IFRS
financial measures, non-IFRS ratios and supplementary financial
measures to evaluate the performance of the Company.
The terms “EBITDA”, "organic revenue", “adjusted net income”,
“adjusted earnings from operations”, “adjusted EBITDA”, “adjusted
basic earnings per share”, and “free cash flow”, are non-IFRS
financial measures, “EBITDA margin”, “adjusted earnings from
operations margin”, “adjusted EBITDA margin”, "organic revenue
growth", “non-cash working capital as a percentage of revenues”,
and “net debt to adjusted EBITDA” are non-IFRS ratios, and
"operating margin", "reoccurring revenues", "custom integration
revenues", "products and equipment revenues", "service including
spare parts revenues", “Order Bookings”, "organic Order Bookings",
"organic Order Bookings growth", “Order Backlog”, and “book-to-bill
ratio” are supplementary financial measures, all of which do not
have any standardized meaning prescribed within IFRS and therefore
may not be comparable to similar measures presented by other
companies. Such measures should not be considered in isolation or
as a substitute for measures of performance prepared in accordance
with IFRS. In addition, management uses “earnings from operations”,
which is an additional IFRS measure, to evaluate the performance of
the Company. Earnings from operations is presented on the Company’s
consolidated statements of income as net income excluding income
tax expense and net finance costs. Operating margin is an
expression of the Company’s earnings from operations as a
percentage of revenues. EBITDA is defined as earnings from
operations excluding depreciation and amortization. EBITDA margin
is an expression of the Company’s EBITDA as a percentage of
revenues. Organic revenue is defined as revenues in the stated
period excluding revenues from acquired companies for which the
acquired company was not a part of the consolidated group in the
comparable period. Organic revenue growth compares the stated
period organic revenue with the reported revenue of the comparable
prior period. Adjusted earnings from operations is defined as
earnings from operations before items excluded from management’s
internal analysis of operating results, such as amortization
expense of acquisition-related intangible assets,
acquisition-related transaction and integration costs,
restructuring charges, the mark-to-market adjustment on stock-based
compensation and certain other adjustments which would be
non-recurring in nature (“adjustment items”). Adjusted earnings
from operations margin is an expression of the Company’s adjusted
earnings from operations as a percentage of revenues. Adjusted
EBITDA is defined as adjusted earnings from operations excluding
depreciation and amortization. Adjusted EBITDA margin is an
expression of the entity’s adjusted EBITDA as a percentage of
revenues. Adjusted basic earnings per share is defined as adjusted
net income on a basic per share basis, where adjusted net income is
defined as adjusted earnings from operations less net finance costs
and income tax expense, plus tax effects of adjustment items and
adjusted for other significant items of a non- recurring nature.
Non-cash working capital as a percentage of revenues is defined as
the sum of accounts receivable, contract assets, inventories,
deposits, prepaids and other assets, less accounts payable, accrued
liabilities, provisions and contract liabilities divided by the
trailing two fiscal quarter revenues annualized. Free cash flow is
defined as cash provided by operating activities less property,
plant and equipment and intangible asset expenditures. Net debt to
adjusted EBITDA is the ratio of the net debt of the Company (cash
and cash equivalents less bank indebtedness, long-term debt, and
lease liabilities) to adjusted EBITDA. Reoccurring revenue for ATS
is defined as revenue from ancillary products and services
associated with equipment sales and revenue from customers who
purchase non-customized ATS products at regular intervals. Custom
integration revenues are defined as revenues from end-to-end
manufacturing solutions customized to customer needs. Products and
equipment revenues are defined as revenues from modular or
standardized equipment and other products. Services including spare
parts revenues are defined as revenues from consulting, digital and
other services, including aftermarket services and spares. Order
Bookings represent new orders for the supply of automation systems,
services and products that management believes are firm. Organic
Order Bookings are defined as Order Bookings in the stated period
excluding Order Bookings from acquired companies for which the
acquired company was not a part of the consolidated group in the
comparable period. Organic Order Bookings growth compares the
stated period organic Order Bookings with the reported Order
Bookings of the comparable prior period. Order Backlog is the
estimated unearned portion of revenues on customer contracts that
are in process and have not been completed at the specified date.
Book to bill ratio is a measure of Order Bookings compared to
revenue.
Following amendments to ATS’ Restricted Stock Unit Plan in 2022
to provide the Company with the option for settlement in shares
purchased in the open market and the creation of the employee
benefit trust to facilitate such settlement, ATS began to account
for equity-settled restricted share units using the equity method
of accounting. However, prior restricted share unit grants which
will be cash-settled and deferred stock unit grants which will be
cash-settled are accounted for as described in the Company's annual
consolidated financial statements and have volatility period over
period based on the fluctuating price of ATS’ common shares.
Certain non-IFRS financial measures (adjusted EBITDA, net debt to
adjusted EBITDA, adjusted earnings from operations and adjusted
basic earnings per share) exclude the impact on stock-based
compensation expense of the revaluation of deferred stock units and
restricted share units resulting specifically from the change in
market price of the Company's common shares between periods.
Management believes that this adjustment provides insight into the
Company's performance, as share price volatility drives variability
in the Company's stock-based compensation expense.
Operating margin, adjusted earnings from operations, EBITDA,
EBITDA margin, adjusted EBITDA, and adjusted EBITDA margin are used
by the Company to evaluate the performance of its operations.
Management believes that earnings from operations is an important
indicator in measuring the performance of the Company’s operations
on a pre-tax basis and without consideration as to how the Company
finances its operations. Management believes that organic revenue
and organic revenue growth, when considered with IFRS measures,
allow the Company to better measure the Company's performance and
evaluate long-term performance trends. Organic revenue growth also
facilitates easier comparisons of the Company's performance with
prior and future periods and relative comparisons to its peers.
Management believes that EBITDA and adjusted EBITDA are important
indicators of the Company’s ability to generate operating cash
flows to fund continued investment in its operations. Management
believes that adjusted earnings from operations, adjusted earnings
from operations margin, adjusted EBITDA, adjusted net income and
adjusted basic earnings per share are important measures to
increase comparability of performance between periods. The
adjustment items used by management to arrive at these metrics are
not considered to be indicative of the business’ ongoing operating
performance. Management uses the measure “non-cash working capital
as a percentage of revenues” to assess overall liquidity. Free cash
flow is used by the Company to measure cash flow from operations
after investment in property, plant and equipment and intangible
assets. Management uses net debt to adjusted EBITDA as a
measurement of leverage of the Company. Reoccurring revenues,
custom integration revenues, products and equipment revenues and
service including spare parts revenues are used by the Company to
understand the revenue portfolio of the Company. Order Bookings
provide an indication of the Company’s ability to secure new orders
for work during a specified period, while Order Backlog provides a
measure of the value of Order Bookings that have not been completed
at a specified point in time. Both Order Bookings and Order Backlog
are indicators of future revenues that the Company expects to
generate based on contracts that management believes to be firm.
Organic Order Bookings and organic Order Bookings growth allow the
Company to better measure the Company's performance and evaluate
long-term performance trends. Organic Order Bookings growth also
facilitates easier comparisons of the Company's performance with
prior and future periods and relative comparisons to its peers.
Book to bill ratio is used to measure the Company’s ability and
timeliness to convert Order Bookings into revenues. Management
believes that ATS shareholders and potential investors in ATS use
these additional IFRS measures and non-IFRS financial measures in
making investment decisions and measuring operational results.
A reconciliation of (i) adjusted EBITDA and EBITDA to net
income, (ii) adjusted net income to net income, (iii) adjusted
basic earnings per share to basic earnings per share (iv) free cash
flow to its IFRS measure components and (vi) organic revenue to
revenue, in each case for the three- and twelve- months ended March
31, 2024 and March 31, 2023, is contained in this document (see
“Reconciliation of Non-IFRS Measures to IFRS Measures”). This
document also contains a reconciliation of (i) non-cash working
capital as a percentage of revenues and (ii) net debt to their IFRS
measure components, in each case at both March 31, 2024 and March
31, 2023 (see “Reconciliation of Non-IFRS Measures to IFRS
Measures”). A reconciliation of adjusted earnings from operations
to earnings from operations for the three- and twelve-months ended
March 31, 2024 and March 31, 2023 is also contained in this
document (see “Consolidated Operating Results"). A reconciliation
of Order Bookings and Order Backlog to total Company revenues for
the three- and twelve-months ended March 31, 2024 and March 31,
2023 is also contained in this document (see “Order Backlog
Continuity”).
Note to Readers: Forward-Looking Statements
This news release contains certain statements that may
constitute forward-looking information and forward-looking
statements within the meaning of applicable Canadian and United
States securities laws ("forward-looking statements"). All such
statements are made pursuant to the “safe harbour” provisions of
Canadian provincial and territorial securities laws and the U.S.
Private Securities Litigation Reform Act of 1995. Forward-looking
statements include all statements that are not historical facts
regarding possible events, conditions or results of operations that
ATS believes, expects or anticipates will or may occur in the
future, including, but not limited to: the value creation strategy;
the Company’s strategy to expand organically and through
acquisition, and the expected benefits to be derived; the ABM;
disciplined acquisitions; various market opportunities for ATS;
expanding in emerging markets; conversion of opportunities into
Order Bookings; the Company’s Order Backlog partially mitigating
the impact of variable Order Bookings; rate of Order Backlog
conversion to revenue; the expected benefits where the Company
engages with customers on enterprise-type solutions and the
potential impact of the Company’s approach to market and timing of
customer decisions on Order Bookings, performance period, and
timing of revenue recognition; the announcement of new Order
Bookings and the anticipated timeline for delivery; potential
impacts on the time to convert opportunities into Order Bookings;
expected benefits with respect to the Company’s efforts to grow its
product portfolio and after-sale service revenues; initiatives in
furtherance of the Company’s goal of expanding its adjusted
earnings from operations margin over the long term and potential
impact of supply chain disruptions; the ability of after-sales
revenues and reoccurring revenues to provide some balance to
customers’ capital expenditure cycles; the range of reoccurring
revenues as a percentage of total revenues; the impact of
developing the Company’s digitalization capabilities, including the
collection and interpretation of data, as a key area of growth, and
to drive meaningful change to optimize performance for customers;
expectation of synergies from integration of acquired businesses;
the closing and completion of any planned acquisitions as
anticipated; the timing and amount of restructuring costs; non-cash
working capital levels as a percentage of revenues in the
short-term and the long-term; reorganization activity, and its
ability to improve the cost structure of the Company, and to be
reallocated to growth areas, and the expected timing and cost of
this reorganization activity; expectation in relation to meeting
liquidity and funding requirements for investments; potential to
use debt or equity financing to support strategic opportunities and
growth strategy; underlying trends driving customer demand;
potential impacts of variability in bookings caused by the
strategic nature and size of electric vehicle programs; revenue
growth in other markets and due to acquisitions to offset any
reduced volumes from the electric vehicle program in fiscal 2025;
expected capital expenditures for fiscal 2025; the uncertainty and
potential impact on the Company’s business and operations due to
the current macroeconomic environment including the impacts of
infectious diseases or any epidemic or pandemic outbreak or
resurgence, inflation, supply chain disruptions, interest rate
changes, energy shortages, global price increases, events involving
limited liquidity, defaults, non-performance or other adverse
developments that affect financial institutions, transactional
counterparties or other companies in the financial services
industry generally, or concerns or rumours about any events of
these kinds or other similar risks that have in the past and may in
the future lead to market-wide liquidity problems, and regional
conflicts; the Company’s belief with respect to the outcome of
certain lawsuits, claims and contingencies; and the expectation
that changes in accounting standards will not have a material
effect on the Company's financial statements.
Forward-looking statements are inherently subject to significant
known and unknown risks, uncertainties, and other factors that may
cause the actual results, performance, or achievements of ATS, or
developments in ATS’ business or in its industry, to differ
materially from the anticipated results, performance, achievements,
or developments expressed or implied by such forward-looking
statements. Important risks, uncertainties, and factors that could
cause actual results to differ materially from expectations
expressed in the forward-looking statements include, but are not
limited to: the impact of regional or global conflicts; general
market performance including capital market conditions and
availability and cost of credit; performance of the markets that
ATS serves; industry challenges in securing the supply of labour,
materials, and, in certain jurisdictions, energy sources such as
natural gas; impact of inflation; interest rate changes; foreign
currency and exchange risk; the relative strength of the Canadian
dollar; risks related to customer concentration; risks related to a
recession, slowdown, and/or sustained downturn in the economy;
impact of factors such as increased pricing pressure, increased
cost of energy and supplies, and delays in relation thereto, and
possible margin compression; the regulatory and tax environment;
the emergence of new infectious diseases or any epidemic or
pandemic outbreak or resurgence, and collateral consequences
thereof, including the disruption of economic activity, volatility
in capital and credit markets, and legislative and regulatory
responses; the effect of events involving limited liquidity,
defaults, non-performance or other adverse developments that affect
financial institutions, transaction counterparties, or other
companies in the financial services industry generally, or concerns
or rumours about any events of these kinds or other similar risks,
that have in the past and may in the future lead to market-wide
liquidity problems; energy shortages and global prices increases;
inability to successfully expand organically or through
acquisition, due to an inability to grow expertise, personnel,
and/or facilities at required rates or to identify, negotiate and
conclude one or more acquisitions; or to raise, through debt or
equity, or otherwise have available, required capital; that the ABM
is not effective in accomplishing its goals; that ATS is unable to
expand in emerging markets, or is delayed in relation thereto, due
to any number of reasons, including inability to effectively
execute organic or inorganic expansion plans, focus on other
business priorities, or local government regulations or delays;
that the timing of completion of new Order Bookings is other than
as expected due to various reasons, including schedule changes or
the customer exercising any right to withdraw the Order Booking or
to terminate the program in whole or in part prior to its
completion, thereby preventing ATS from realizing on the full
benefit of the program; that some or all of the sales funnel is not
converted to Order Bookings due to competitive factors or failure
to meet customer needs; that the market opportunities ATS
anticipates do not materialize or that ATS is unable to exploit
such opportunities; failure to convert Order Backlog to revenue
and/or variations in the amount of Order Backlog completed in any
given quarter; timing of customer decisions related to large
enterprise programs and potential for negative impact associated
with any cancellations or non-performance in relation thereto; that
the Company is not successful in growing its product portfolio
and/or service offering or that expected benefits are not realized;
that efforts to expand adjusted earnings from operations margin
over long-term are unsuccessful, due to any number of reasons,
including less than anticipated increase in after-sales service
revenues or reduced margins attached to those revenues, inability
to achieve lower costs through supply chain management, failure to
develop, adopt internally, or have customers adopt, standardized
platforms and technologies, inability to maintain current cost
structure if revenues were to grow, and failure of ABM to impact
margins; that after-sales or reoccurring revenues do not provide
the expected balance to customers’ expenditure cycles; that
reoccurring revenues are not in the expected range; the development
of the Company’s digitalization capabilities fails to achieve the
growth or change expected; that planned acquisitions are not closed
as anticipated or at all; that acquisitions made are not integrated
as quickly or effectively as planned or expected and, as a result,
anticipated benefits and synergies are not realized; non-cash
working capital as a percentage of revenues operating at a level
other than as expected due to reasons, including, the timing and
nature of Order Bookings, the timing of payment milestones and
payment terms in customer contracts, and delays in customer
programs; that planned reorganization activity does not succeed in
improving the cost structure of the Company or that the investment
is not reallocated to growth areas, or is not completed at the cost
or within the timelines expected, or at all; underlying trends
driving customer demand will not materialize or have the impact
expected; that capital expenditure targets are increased in the
future or the Company experiences cost increases in relation
thereto; risk that the ultimate outcome of lawsuits, claims, and
contingencies give rise to material liabilities for which no
provisions have been recorded; the impact on the Company’s
financial statements of changes in accounting standards; the
consequence of activist initiatives on the business performance,
results, or share price of the Company; the impact of analyst
reports on price and trading volume of ATS’ shares; and other risks
and uncertainties detailed from time to time in ATS' filings with
securities regulators, including, without limitation, the risk
factors described in ATS’ annual information form for the fiscal
year ended March 31, 2024, which are available on the System for
Electronic Data Analysis and Retrieval + ("SEDAR+") at
www.sedarplus.com and on the U.S. Securities Exchange Commission’s
Electronic Data Gatherin, Analysis and Retrieval System ("EDGAR")
at www.sec.gov. ATS has attempted to identify important factors
that could cause actual results to materially differ from current
expectations, however, there may be other factors that cause actual
results to differ materially from such expectations.
Forward-looking statements are necessarily based on a number of
estimates, factors, and assumptions regarding, among others,
management's current plans, estimates, projections, beliefs and
opinions, the future performance and results of the Company’s
business and operations; the ability of ATS to execute on its
business objectives; and general economic and political conditions,
and global events, including any epidemic or pandemic outbreak or
resurgence.
Forward-looking statements included in this news release are
only provided to understand management’s current expectations
relating to future periods and, as such, are not appropriate for
any other purpose. Although ATS believes that the expectations
reflected in such forward-looking statements are reasonable, such
statements involve risks and uncertainties, and ATS cautions you
not to place undue reliance upon any such forward-looking
statements, which speak only as of the date they are made. ATS does
not undertake any obligation to update forward-looking statements
contained herein other than as required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240516233307/en/
For more information, contact: David Galison Head of
Investor Relations ATS Corporation 730 Fountain Street North
Cambridge, ON, N3H 4R7 (519) 653-6500 dgalison@atsautomation.com
For general media inquiries, contact: Matthew Robinson
Director, Corporate Communications ATS Corporation 730 Fountain
Street North Cambridge, ON, N3H 4R7 (519) 653-6500
mrobinson@atsautomation.com
ATS (NYSE:ATS)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025
ATS (NYSE:ATS)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025